cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ligand Pharmaceuticals Incorporated
1 own
7 watching
Current Price
$70.29
$0.57
(0.82%)
logo-lgnd
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,187.48M
52-Week High
52-Week High
83.95
52-Week Low
52-Week Low
45.2519
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
54.9356
iconMarket Capitalization1,187.48M
icon52-Week High83.95
icon52-Week Low45.2519
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio54.9356
What does the Ligand Pharmaceuticals Incorporated do?
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis and Evomela, which are used to treat multiple myeloma; CorMatrix portfolio of vascular, cardiac, and pericardial tissue repair products; bazedoxifene, which is used for the treatment of postmenopausal osteoporosis; Carnexiv that is used as replacement therapy for oral carbamazepine formulations; Nexterone, a Captisol-enabled formulation of amiodarone; Noxafil-IV, a Captisol-enabled formulation of posaconazole for IV use; Exemptia for autoimmune diseases; and Vivitra for breast cancer. The company's partners programs, which are in clinical development used for the treatment of seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, kidney disease, and others. Its internal development program comprise products for the treatment of Type 2 diabetes mellitus, oncology, allergy, anti-coagulant, depression, sun damage, blood disorders, and diabetes. The company is also involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated has alliances, licenses, and other business relationships with various pharmaceutical companies, including Novartis AG; Amgen, Inc.; Merck & Co., Inc.; Pfizer Inc.; Celgene; Gilead Sciences; Janssen Biotech, Inc.; Baxter International, Inc.; and Eli Lilly and Company. The company was founded in 1987 and is headquartered in San Diego, California.
Read More
How much money does Ligand Pharmaceuticals Incorporated make?
News & Events about Ligand Pharmaceuticals Incorporated.
Business Wire
22days ago
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Novan, Inc. (Nasdaq: NOVN) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking marketing approval for berdazimer gel, 10.3% (SB206) for the topical treatment of molluscum...
Globe Newswire
1month ago
Posters were presented Dec. 9 at the San Antonio Breast Cancer Symposium (SABCS)One abstract addressed patients who participated in the randomized Phase 2 ELAINE 1 study that assessed investigational lasofoxifene versus fulvestrantSecond abstract addressed patients who participated in a single-arm ...
Business Wire
1month ago
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that at todays Investor and Analyst Day event its executive management provided an overview of Ligands corporate structure and business following the successful spin-off of its OmniAb antibody discovery business, reviewed Ligands recent...
Globe Newswire
1month ago
Study evaluated safety, tolerability and pharmacokinetics of oral lasofoxifene in healthy Japanese and Caucasian womenCOLUMBUS, Ohio, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ...
Globe Newswire
2 months ago
COLUMBUS, Ohio, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative targeted therapeutics to specifically treat ESR1-mutated metastatic breast and gynecological cancers, today announced that it had four abstracts accepted ...
Frequently Asked Questions
Frequently Asked Questions
What is Ligand Pharmaceuticals Incorporated share price today?
plus_minus_icon
Can Indians buy Ligand Pharmaceuticals Incorporated shares?
plus_minus_icon
How can I buy Ligand Pharmaceuticals Incorporated shares from India?
plus_minus_icon
Can Fractional shares of Ligand Pharmaceuticals Incorporated be purchased?
plus_minus_icon
What are the documents required to start investing in Ligand Pharmaceuticals Incorporated stocks?
plus_minus_icon
What is today’s traded volume of Ligand Pharmaceuticals Incorporated?
plus_minus_icon
What is today’s market capitalisation of Ligand Pharmaceuticals Incorporated?
plus_minus_icon
What is the 52-Week High and Low Range of Ligand Pharmaceuticals Incorporated?
plus_minus_icon
What percentage is Ligand Pharmaceuticals Incorporated down from its 52-Week High?
plus_minus_icon
What percentage is Ligand Pharmaceuticals Incorporated up from its 52-Week Low?
plus_minus_icon
Current Price
$70.29
$0.57
(0.82%)
logo-lgnd
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00